Eisbach Bio GmbH
eisbach.bio
Health Care
Oncology Therapeutics
Biotechnology
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Dec 2024 · 22 mo ago
Team
11-50
employees, estimated range
Grants
$6.8M
4 grants · CORDIS
The money's age
Due for its next round
22 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 1
Won a grant $596k · CORDIS
Dec 23, 2024
Raised a round Venture round
May 1, 2023
Won a grant $270k · CORDIS
Jun 1, 2021
Won a grant $4.7M · CORDIS
Oct 28, 2020
Raised a round Venture round
May 1, 2020
Won a grant $1.3M · CORDIS
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | May 2026 | $596k | — | CORDIS |
| Venture round | Dec 2024 | — | — | handelsregister.de |
| Grant | May 2023 | $270k | — | CORDIS |
| Grant | Jun 2021 | $4.7M | — | CORDIS |
| Venture round | Oct 2020 | — | — | handelsregister.de |
| Grant | May 2020 | $1.3M | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Eisbach Bio GmbH | its site |
| Registered | 7 Jan 2019 |
Investors in similar startupsfunds that back the companies most like this one
backs Alterome, Avenzo Therapeutics
backs PLEASE READ THIS AG
backs Avenzo Therapeutics
backs Alterome
Similar startupsby what they do, their industry and backers
Avenzo Therapeutics is a clinical-stage biotechnology company that develops next-generation targeted oncology therapies. It was co-founded…
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and…
BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the…
Accent is pioneering a new class of small molecule precision cancer therapies that target critical intracellular dependencies that span…
Creating neoantigens by design… …to transform cancer treatments into cures. ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE…
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Planegg
Germany
HQ
10-50 est. staff
Am Klopferspitz 19, Planegg, 82152, DE